First human doses of experimental drug given in safety trial
Knowledge-focused
Completed
This was the first study to test a new drug called OPT101 in people. It aimed to find a safe dose and see how the body processes it. The study involved 14 healthy volunteers who received either the drug or a placebo. Researchers closely monitored participants for any side effects…
Phase: PHASE1 • Sponsor: Op-T LLC • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC